AGF INVESTMENTS INC. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 48 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AGF INVESTMENTS INC. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2022$940,000
-21.2%
670,000
-25.6%
0.01%0.0%
Q3 2021$1,193,000
-0.8%
900,0000.0%0.01%0.0%
Q2 2021$1,203,000
-0.6%
900,0000.0%0.01%
-10.0%
Q1 2021$1,210,000
-29.9%
900,000
-28.0%
0.01%
-33.3%
Q4 2020$1,725,000
+25.5%
1,250,000
+25.0%
0.02%
+7.1%
Q3 2020$1,375,0001,000,0000.01%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders